Samuel D. Colella, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 2,713,121 shares at $13.00 ($4.0M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market purchase of $4.0M FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,405,429 | $0 | 0.0% |
| 2 | $13.00 | 307,692 | $4.0M | 100.0% |
| Total | $1.47 avg | 2,713,121 | $4.0M | 100% |
| Filing → |
| FLDM | BUY | 2019-08-12 | $7K | — | Filing → |
| FLXN | BUY | 2019-08-09 | $21K | — | Filing → |
| FLDM | BUY | 2019-08-08 | $63K | — | Filing → |